15.全身性エリテマトーデスの臓器病変と治療

Saved in:
Bibliographic Details
Published in日本内科学会雑誌 Vol. 108; no. 9; pp. 1962 - 1967
Main Author 藤井, 隆夫
Format Journal Article
LanguageJapanese
Published 一般社団法人 日本内科学会 10.09.2019
Subjects
Online AccessGet full text
ISSN0021-5384
1883-2083
DOI10.2169/naika.108.1962

Cover

Author 藤井, 隆夫
Author_xml – sequence: 1
  fullname: 藤井, 隆夫
  organization: 和歌山県立医科大学附属病院リウマチ・膠原病科
BookMark eNo9kDtLw1AcxS9SwVi7-i0S7yP3eu8iaPEFBRedwz_JjSbWKkkXN5vQVhcXB-niJBgUHNzUfptLH5tfwVrF5ZzhHA78zjKqtM5bGqFVgh1KhFprQXwKDsHSIUrQBWQRKZlNsWQVZGFMic2ZdJdQLctiH7tMcEmYa6ENwr-Gt6NuOf14GV89mbw0xbMpeqZ4MMW1KYam6Jv83XRep_270aCc3HdHjzemU47fPieDfAUtRtDMdO3Pq-hoZ_uwvmc3Dnb365sNOyFcujb1FRbgch1in3PMQgqaBlpL4CFlCqL10Gc60kJxDiAliEBJItWsIBiBiFXR1u9ukrXhWHsXaXwG6aUHaTsOmtqb43szfE_N9eeE_zA4gdRLgH0DjoVsnw
ContentType Journal Article
Copyright 2019 一般社団法人 日本内科学会
Copyright_xml – notice: 2019 一般社団法人 日本内科学会
DOI 10.2169/naika.108.1962
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1883-2083
EndPage 1967
ExternalDocumentID article_naika_108_9_108_1962_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
DIK
F5P
JSF
OK1
RJT
ID FETCH-LOGICAL-j1584-2b906a45ed0b5503d2ae2cee8a5d239af7db3efe6955aa88a6c98189e8a631af3
ISSN 0021-5384
IngestDate Wed Sep 03 06:30:13 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 9
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j1584-2b906a45ed0b5503d2ae2cee8a5d239af7db3efe6955aa88a6c98189e8a631af3
OpenAccessLink https://www.jstage.jst.go.jp/article/naika/108/9/108_1962/_article/-char/ja
PageCount 6
ParticipantIDs jstage_primary_article_naika_108_9_108_1962_article_char_ja
PublicationCentury 2000
PublicationDate 2019/09/10
PublicationDateYYYYMMDD 2019-09-10
PublicationDate_xml – month: 09
  year: 2019
  text: 2019/09/10
  day: 10
PublicationDecade 2010
PublicationTitle 日本内科学会雑誌
PublicationTitleAlternate 日内会誌
PublicationYear 2019
Publisher 一般社団法人 日本内科学会
Publisher_xml – name: 一般社団法人 日本内科学会
References 12) van Vollenhoven RF, et al: Remission in SLE: closing in on the target. Ann Rheum Dis 74: 2103-2106, 2015.
8) Stohl W, et al: B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. Arthritis Rheum 48: 3475-3486, 2003.
9) Jacob CO, et al: Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF. J Immunol 177: 2671-2680, 2006.
2) Tedeschi SK, et al: Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus. Ann Rheum Dis 78: 634-640, 2019.
10) Zhang F, et al: A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea. Ann Rheum Dis 77: 355-363, 2018.
5) Jorge A, et al: Hydroxychloroquine retinopathy - implications of research advances for rheumatology care. Nat Rev Rheumatol 14: 693-703, 2018.
3) Fanouriakis A, et al: 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 78: 736-745, 2019. doi: 10.1136/annrheumdis-2019-215089.
4) Yokogawa N, et al: Effects of hydroxychloroquine in patients with cutaneous lupus erythematosus: a multicenter, double-blind, randomized, parallel-group trial. Arthritis Rheumatol 69: 791-799, 2017.
6) Appel GB, et al: Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol 20: 1103-1112, 2009.
7) Dooley MA, et al: Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis. N Engl J Med 365: 1886-1895, 2011.
1) 東條 毅: 抗核抗体の歴史. 日内会誌 91: 2560-2566, 2002.
11) van Vollenhoven RF, et al: Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis 73: 958-967, 2014.
References_xml – reference: 1) 東條 毅: 抗核抗体の歴史. 日内会誌 91: 2560-2566, 2002.
– reference: 2) Tedeschi SK, et al: Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus. Ann Rheum Dis 78: 634-640, 2019.
– reference: 4) Yokogawa N, et al: Effects of hydroxychloroquine in patients with cutaneous lupus erythematosus: a multicenter, double-blind, randomized, parallel-group trial. Arthritis Rheumatol 69: 791-799, 2017.
– reference: 8) Stohl W, et al: B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. Arthritis Rheum 48: 3475-3486, 2003.
– reference: 9) Jacob CO, et al: Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF. J Immunol 177: 2671-2680, 2006.
– reference: 10) Zhang F, et al: A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea. Ann Rheum Dis 77: 355-363, 2018.
– reference: 11) van Vollenhoven RF, et al: Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis 73: 958-967, 2014.
– reference: 3) Fanouriakis A, et al: 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 78: 736-745, 2019. doi: 10.1136/annrheumdis-2019-215089.
– reference: 5) Jorge A, et al: Hydroxychloroquine retinopathy - implications of research advances for rheumatology care. Nat Rev Rheumatol 14: 693-703, 2018.
– reference: 7) Dooley MA, et al: Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis. N Engl J Med 365: 1886-1895, 2011.
– reference: 12) van Vollenhoven RF, et al: Remission in SLE: closing in on the target. Ann Rheum Dis 74: 2103-2106, 2015.
– reference: 6) Appel GB, et al: Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol 20: 1103-1112, 2009.
SSID ssib043658134
ssj0066765
ssib002821954
ssib005879745
ssib007485360
ssib058493862
ssib000940260
ssib002484664
Score 2.1889427
SourceID jstage
SourceType Publisher
StartPage 1962
SubjectTerms ヒドロキシクロロキン
ベリムマブ
ミコフェノール酸モフェチル
全身性エリテマトーデス
目標達成に向けた治療
Title 15.全身性エリテマトーデスの臓器病変と治療
URI https://www.jstage.jst.go.jp/article/naika/108/9/108_1962/_article/-char/ja
Volume 108
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 日本内科学会雑誌, 2019/09/10, Vol.108(9), pp.1962-1967
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1Na9VAcKkVxIv4id_04J4ktZvNJrsIwuaZUpQKQgsFD2Hz8Q7v8BR5vXiyL9TqxYsH6cWT4EPBgze1_ya8tjf_gjOb5L086MHWS9jMzs7O7Gwys8nsLCF3cjC6WSq6jhRd3_EEkw7YHeO4Js8k_tYxXdycvPrEX1n3Hm2IjblTz1pRS5uDZDF9deS-kpNoFWCgV9wlewzNTogCAMqgX7iChuH6TzpmgkbLNOxQGdFIUCmoljSSNNRUhzTyMYxBBzTiVLq2Cgqcal0XpF8XVNRAGhygWUOa5qGyBUZ1hF0AXHHsVClLGW4DZAAgGtzTCbJENkJoHlocRatDgBp_GGuhoRa20KG6YwXxLakAmVfM0nxINXDrIWMK-FdUhbZKojhy8qkXAUjPs7iaKoFzyOJrK69lT4ftjx3MRnPVYa84PW1biYOHgkrLlKUZ2mGGnjW3YnGkX3UU6rsnk6VtNlzmgGWovnzklaWQksNkrE7hmZiSJdl6ZlTLMMCLzm05GXAbHGXAXOZj_tc-bh_D8M_FabuZpOD1lIstIiZ5jZW9InrcVOK-vbgHi4fTbhDYGIbHT1u-t_Iwn1zLV5MzRw3AWpy1cwUKGaj20QiBB57etL3HwZdl01yD4NgqLv1JLjeMpa6OE6nHssqgigLfmxUXfMEerIyaqErr6K2dJ-fqFdqCrsS7QOZ65iI5s1rHoFwiD5j4s_d-vD06_PVt__WXcjgqi69l8aYsPpXF27LYK4udcviz3Pp-uPNhvDs6-Lg9_vyu3Brt__h9sDu8TNaXo7XOilOfQuL0GAjhuIla8o0n8mwpgeU8z-A15oJrKY3IXA7vsiBLeN7NfSWEMVIaP1XgBStA8DkzXX6FzPef9_OrZMFwnrIs9YRwE3DcE2NYnhoYZRgFTwX8GrlfSR6_qFLNxMfR8_X_an2DnJ0-cDfJ_ODlZn4L_O1BctvOm78b1akE
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=15%EF%BC%8E%E5%85%A8%E8%BA%AB%E6%80%A7%E3%82%A8%E3%83%AA%E3%83%86%E3%83%9E%E3%83%88%E3%83%BC%E3%83%87%E3%82%B9%E3%81%AE%E8%87%93%E5%99%A8%E7%97%85%E5%A4%89%E3%81%A8%E6%B2%BB%E7%99%82&rft.jtitle=%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A%E9%9B%91%E8%AA%8C&rft.au=%E8%97%A4%E4%BA%95%2C+%E9%9A%86%E5%A4%AB&rft.date=2019-09-10&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A&rft.issn=0021-5384&rft.eissn=1883-2083&rft.volume=108&rft.issue=9&rft.spage=1962&rft.epage=1967&rft_id=info:doi/10.2169%2Fnaika.108.1962&rft.externalDocID=article_naika_108_9_108_1962_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-5384&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-5384&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-5384&client=summon